Gut microbiome influences efficacy of PD-1based immunotherapy against epithelial tumors

This piece of research is behind the headline: Gut bacteria " boost " cancer therapy. This early-stage study gives us some insights into factors that might influence people ' s responses to a specific type of cancer treatment (immunotherapy with monoclonal antibodies). The findings are of interest, but don ' t have any immediate implications for cancer treatment. This early-stage study gives us some insights into factors that might influence people ' s responses to a specific type of cancer treatment (immunotherapy with monoclonal antibodies).The findings are of interest, but don ' t have any immediate implications for cancer treatment.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news